STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 18 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q4 2016. The put-call ratio across all filers is - and the average weighting 2.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $5,470,000 | -58.1% | 2,279,099 | -8.9% | 0.78% | -42.5% |
Q3 2016 | $13,059,000 | +22.6% | 2,501,667 | -6.5% | 1.35% | -8.6% |
Q2 2016 | $10,648,000 | -13.2% | 2,675,338 | -0.6% | 1.47% | -6.0% |
Q1 2016 | $12,270,000 | -40.0% | 2,690,702 | 0.0% | 1.57% | -22.5% |
Q4 2015 | $20,449,000 | – | 2,690,702 | – | 2.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 978,907 | $6,865,000 | 3.28% |
RA Capital Management | 2,690,702 | $20,449,000 | 2.02% |
NEA Management Company, LLC | 2,141,308 | $16,274,000 | 1.04% |
Broadfin Capital, LLC | 1,656,705 | $10,911,000 | 0.67% |
Tredje AP-fonden | 909,581 | $6,913,000 | 0.44% |
Granite Point Capital Management, L.P. | 388,945 | $2,679,000 | 0.40% |
Ghost Tree Capital, LLC | 72,726 | $553,000 | 0.23% |
SPHERA FUNDS MANAGEMENT LTD. | 181,818 | $1,382,000 | 0.20% |
Tower Research Capital LLC (TRC) | 1,094 | $8,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 1,373 | $10,000 | 0.00% |